Envista Holdings Corporation (NVST)

NYSE: NVST · IEX Real-Time Price · USD
42.18
-0.74 (-1.72%)
May 18, 2022 11:28 AM EDT - Market open
Market Cap6.86B
Revenue (ttm)2.63B
Net Income (ttm)343.70M
Shares Out162.62M
EPS (ttm)1.91
PE Ratio22.04
Forward PE20.58
Dividendn/a
Ex-Dividend Daten/a
Volume224,349
Open42.91
Previous Close42.92
Day's Range42.18 - 43.28
52-Week Range37.60 - 52.03
Beta1.59
AnalystsBuy
Price Target56.21 (+33.3%)
Earnings DateMay 4, 2022

About NVST

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Imp...

IndustryHealth Care Equipment & Supplies
IPO DateSep 18, 2019
CEOAmir Aghdaei
Employees11,200
Stock ExchangeNYSE
Ticker SymbolNVST
Full Company Profile

Financial Performance

In 2021, NVST's revenue was $2.51 billion, an increase of 30.06% compared to the previous year's $1.93 billion. Earnings were $340.50 million, an increase of 922.52%.

Financial Statements

Analyst Forecast

According to 17 analysts, the average rating for NVST stock is "Buy." The 12-month stock price forecast is 56.21, which is an increase of 33.26% from the latest price.

Price Target
$56.21
(33.26% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESS

BREA, Calif. , May 17, 2022  /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allot...

18 hours ago - PRNewsWire

Envista Announces Participation in William Blair Emerging Technologies in Dental Care Virtual Conference

BREA, Calif. , May 16, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in William Blair Emerging Technologies in Dental Care ...

1 day ago - PRNewsWire

Envista (NVST) Q1 Earnings and Revenues Top Estimates

Envista (NVST) delivered earnings and revenue surprises of 6.82% and 0.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Envista Reports First Quarter 2022 Earnings

BREA, Calif. , May 4, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2022.

1 week ago - PRNewsWire

Analysts Estimate Envista (NVST) to Report a Decline in Earnings: What to Look Out for

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

Envista Completes Acquisition of Carestream Dental's Intraoral Scanner Business

BREA, Calif., April 20, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the completion of the acquisition of Carestream Dental's Intraoral Scanner business.

3 weeks ago - PRNewsWire

Envista Schedules First Quarter 2022 Earnings Call

BREA, Calif. , April 13, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2022 on Wednesday, May 4, 2022.

1 month ago - PRNewsWire

Envista Announces DEXIS Brand Name for Imaging Business

BREA, Calif. , March 29, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced Envista's KaVo imaging business will be re-branded as "DEXIS".

1 month ago - PRNewsWire

Envista Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing

BREA, Calif. , March 28, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Int...

1 month ago - PRNewsWire

Envista Announces Participation in Piper Sandler

BREA, Calif. , March 17, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Piper Sandler Dental Day on Tuesday, March 29 th ...

2 months ago - PRNewsWire

Envista To Hold Investor Day at Envista Summit

BREA, Calif., March 7, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Day at its Envista Summit on Friday, April 1 st from 8:...

2 months ago - PRNewsWire

Envista Announces Participation in Jefferies Virtual Dental Summit

BREA, Calif., Feb. 22, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, Februa...

2 months ago - PRNewsWire

Envista (NVST) Beats Q4 Earnings and Revenue Estimates

Envista (NVST) delivered earnings and revenue surprises of 9.52% and 2.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Envista Reports Fourth Quarter 2021 Earnings

BREA, Calif., Feb. 9, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter and fiscal year 2021.

3 months ago - PRNewsWire

Envista Renews Commercial Partnership with Vitaldent Group

BREA, Calif., Feb. 7, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced that it has renewed its partnership agreement with the Vitaldent Group, a leading Spanish Dental Service Or...

3 months ago - PRNewsWire

Why Envista (NVST) Could Beat Earnings Estimates Again

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Envista and Pacific Dental Services Announce Extension of Implant, Imaging, and Clear Aligner Commercial Relationship

BREA, Calif., Jan. 31, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- and leading dental support organization Pacific Dental Services® (PDS) announced today the extension ...

3 months ago - PRNewsWire

Envista Schedules Fourth Quarter 2021 Earnings Call

BREA, Calif., Jan. 19, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022.

3 months ago - PRNewsWire

Envista and Pacific Dental Services Announce Assisted Intelligence Development Partnership

BREA, Calif., Jan. 10, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services®  (PDS) announce today the co...

4 months ago - PRNewsWire

Envista Closes Divestiture of KaVo Treatment Unit & Instrument Business

BREA, Calif., Jan. 3, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrume...

4 months ago - PRNewsWire

Envista (NVST) Gets FDA 510 (k) Approval for N1 Implant System

Envista (NVST) noted that the Nobel Biocare N1 system represents a significant step further in patient-centric dental implant solutions.

4 months ago - Zacks Investment Research

Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1™ Implant System

BREA, Calif., Dec. 27, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ impla...

4 months ago - PRNewsWire

Update to Envista participation at J.P. Morgan Healthcare Conference

BREA, Calif., Dec. 23, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P.

4 months ago - PRNewsWire

ENVISTA TO ACQUIRE CARESTREAM DENTAL INTRA-ORAL SCANNER BUSINESS

BREA, Calif., Dec. 22, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Sca...

4 months ago - PRNewsWire